International
US drug agency approves new mRNA vaccine for influenza
A new mRNA vaccine by Moderna for influenza has been authorized in the US. This marks the first approval of a flu vaccine based solely on mRNA technology.
The US drug agency has approved a new vaccine from Moderna based on mRNA technology, set to be available for the flu season. This approval marks a significant step, as it is the world's first flu vaccine to exclusively utilize this technology.
Despite the approval, skepticism is being voiced within the US Department of Health. The specific reasons for this skepticism have not been detailed, but there are uncertainties about how the new vaccine will perform in widespread use.